These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22490991)

  • 21. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.
    Targher G; Bertolini L; Rodella S; Zoppini G; Lippi G; Day C; Muggeo M
    Diabetologia; 2008 Mar; 51(3):444-50. PubMed ID: 18058083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago Hospital.
    Muddu M; Mutebi E; Mondo C
    Afr Health Sci; 2016 Mar; 16(1):183-93. PubMed ID: 27358631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Giunti S; Bargero G; Ferrero S; Pagano G; Perin PC
    Diabet Med; 2004 Aug; 21(8):823-8. PubMed ID: 15270784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
    Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
    Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
    Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cottone S; Cerasola G
    J Hypertens; 2009 Mar; 27(3):633-41. PubMed ID: 19262231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: impact of different echocardiographic and ultrasonographic diagnostic criteria.
    Cuspidi C; Lonati L; Macca G; Sampieri L; Fusi V; Michev I; Severgnini B; Salerno M; Magrini F; Zanchetti A
    Blood Press; 2001; 10(3):142-9. PubMed ID: 11688761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Zanchetti A
    J Hypertens; 2006 Aug; 24(8):1671-7. PubMed ID: 16877972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cottone S; Cerasola G
    J Hum Hypertens; 2011 Mar; 25(3):144-51. PubMed ID: 20944658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
    Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
    Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular geometry in Nigerians with type II diabetes mellitus.
    Baba MM; Balogun MO; Akintomide AO; Adebayo RA; Talle MA; Akinwusi PO; Abdul H; Danbauchi SS
    Nig Q J Hosp Med; 2012; 22(3):152-7. PubMed ID: 24564090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echocardiography in Low-Risk Hypertensive Patients.
    Mancusi C; Angeli F; Verdecchia P; Poltronieri C; de Simone G; Reboldi G
    J Am Heart Assoc; 2019 Dec; 8(24):e013497. PubMed ID: 31838971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular hypertrophy in nondiabetic predialysis CKD.
    Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
    Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.
    Goland S; Shimoni S; Zornitzki T; Knobler H; Azoulai O; Lutaty G; Melzer E; Orr A; Caspi A; Malnick S
    J Clin Gastroenterol; 2006; 40(10):949-55. PubMed ID: 17063117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.
    Yan LH; Mu B; Guan Y; Liu X; Zhao N; Pan D; Wang SZ
    J Diabetes Investig; 2016 Nov; 7(6):889-894. PubMed ID: 27181828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment.
    Sato A; Tarnow L; Nielsen FS; Knudsen E; Parving HH
    QJM; 2005 Dec; 98(12):879-84. PubMed ID: 16272208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension.
    Catena C; Bernardi S; Sabato N; Grillo A; Ermani M; Sechi LA; Fabris B; Carretta R; Fallo F
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):389-93. PubMed ID: 22796347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study.
    de Simone G; Wang W; Best LG; Yeh F; Izzo R; Mancusi C; Roman MJ; Lee ET; Howard BV; Devereux RB
    Cardiovasc Diabetol; 2017 May; 16(1):64. PubMed ID: 28499385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.